Stereotaxis, Inc. (NASDAQ:STXS)

CAPS Rating: 3 out of 5

The Company designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital's interventional surgical suite, or cath lab.

Recs

0
Player Avatar 20100626 (< 20) Submitted: 7/17/2010 12:53:57 PM : Outperform Start Price: $3.63 STXS Score: -115.41

Bravobevo

Featured Broker Partners


Advertisement